BRIEF-Mast Therapeutics reports Q1 loss per share of $0.06

* Mast therapeutics reports first quarter 2016 financial results and recent highlights
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.